L-Phenylglycine methyl ester hydrochloride is a protected amino acid derivative in which the amino acid backbone of phenylglycine is converted to a methyl ester and the amino functionality is present as a hydrochloride salt, classifying it as an amino ester salt rather than a free amino acid. The molecule bears a benzyl-like side chain (phenylmethyl substituent) and retains the esterified carboxyl group, while the protonated amino group forms an ammonium chloride that can influence solubility and suppress unproductive side reactions during handling. In synthesis, this compound is used as a substrate building block for preparing phenylglycine-containing peptides and peptide-related intermediates, including contexts where controlled reactivity of the carboxyl and amino functionalities is required for coupling and subsequent derivatization.
L-Phenylglycine methyl ester hydrochloride is the hydrochloride salt of the methyl ester of L-phenylglycine, featuring a chiral α-amino acid framework with a benzyl-like phenyl side chain that supports stereochemically defined peptide coupling. The structure combines a protected/activated carboxyl functionality as a methyl ester with a protonated amine under hydrochloride salt conditions, which improves handling while remaining compatible with standard amino acid derivatization logic. The aromatic phenyl ring provides a stable hydrophobic handle for molecular recognition and for generating peptidomimetic motifs, while the ester group enables downstream transformations such as selective hydrolysis, transesterification, or conversion to amide/acid derivatives. The chiral center and ester/amine functionality together position this compound as a chiral amino acid intermediate for peptide building block preparation and for stereocontrolled synthesis of phenylglycine-containing analogs.
1. Peptide Synthesis
L-Phenylglycine methyl ester hydrochloride serves as a chiral amino acid ester intermediate for peptide building block preparation and coupling chemistry. The L-configuration at the α-carbon and the phenyl side chain allow incorporation of phenylglycine residues into peptide sequences or peptide-like scaffolds after conversion of the methyl ester to the corresponding activated carboxyl form. The hydrochloride salt form supports controlled amine availability during protection and coupling steps, enabling compatibility with common peptide coupling strategies and protecting-group workflows. The resulting phenylglycine-containing intermediates can be used to generate dipeptides, longer peptide fragments, or peptidomimetic chains where aromatic side-chain presentation is required for conformational bias and binding studies. Downstream peptide synthesis benefits from the ability to tune the C-terminal state by ester hydrolysis or activation prior to amide bond formation.
2. Amino Acid Derivatization
L-Phenylglycine methyl ester hydrochloride functions as an amino acid ester for side-chain and carboxyl functional group transformations in synthetic organic chemistry. The methyl ester can be selectively converted to carboxylic acids for further coupling, to acid chlorides/activated esters for rapid derivatization, or to alternative ester forms to match specific protecting-group strategies. The benzyl-like phenyl moiety can be leveraged for aromatic substitution or for constructing phenylglycine-based heteroaromatic precursors via established aromatic functionalization routes. The chiral center enables stereodefined generation of derivatives used in structure-activity relationship studies, fragment elaboration, and stereochemical mapping of analog series. The compound's salt form also supports reproducible handling in derivatization sequences that require controlled amine reactivity.
3. Peptidomimetics And SAR
L-Phenylglycine methyl ester hydrochloride supports peptidomimetic construction where phenylglycine stereochemistry and aromatic side-chain geometry influence conformational preferences. The phenyl side chain provides an aryl hydrophobic element that can be maintained while the ester functionality is adjusted to match the desired C-terminal motif, such as converting to acids or amide-forming derivatives for incorporation into constrained analogs. The L-stereocenter allows systematic SAR studies across stereochemically consistent series, including analogs designed to probe backbone flexibility, aromatic packing, and binding-site hydrophobic interactions. The compound can be used to prepare fragment-sized building blocks that feed into combinatorial peptide analog synthesis and medicinal chemistry library workflows. Phenylglycine-based intermediates derived from this material can also be used to generate non-natural amino acid variants where the ester-to-amide conversion defines the final scaffold connectivity.
4. Chiral Building Block Development
L-Phenylglycine methyl ester hydrochloride is suitable as a chiral amino acid intermediate for stereocontrolled synthesis of L-configured phenylglycine derivatives. The combination of a defined L-α-amino stereocenter and a functional methyl ester supports controlled downstream conversion to N-protected amino acid derivatives and C-terminal activation states required for sequential assembly. The hydrochloride salt form helps manage amine protonation during protection/deprotection planning, supporting compatibility with orthogonal protecting-group strategies used to prevent racemization and maintain stereochemical integrity. The aromatic side chain can be retained through multiple synthetic steps, enabling late-stage functionalization of the carboxyl functionality without disturbing the stereocenter. Chiral intermediates prepared from this compound can be employed in asymmetric synthesis planning, stereochemical quality control workflows, and the preparation of reference materials for analytical characterization of phenylglycine-containing structures.
5. Pharmaceutical Intermediate Preparation
L-Phenylglycine methyl ester hydrochloride can be applied in pharmaceutical intermediate preparation where phenylglycine fragments are required for constructing drug-like amide or peptide-derived motifs. The methyl ester provides a manufacturable handle for converting to carboxylic acid or activated carboxyl derivatives under process-compatible conditions, enabling scalable access to C-terminal coupling partners. The amine hydrochloride salt supports predictable reactivity management during protection steps, aligning with industrial protecting-group logic that separates N-functionalization from C-terminal activation. The phenylglycine aromatic side chain can be carried through intermediate sequences to maintain structural identity while downstream transformations generate final amide linkages or polymerizable functionalities. The resulting phenylglycine-based intermediates are relevant to fine chemical synthesis and process chemistry routes that require stereochemically defined amino acid building blocks for downstream assembly into larger target molecules.
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More